, /PRNewswire/ -- Precision for Medicine, a global leader in biomarker-driven clinical research and development, today announced that , MD, has joined the company as Chief Medical Officer. Dr. Singh was previously Division Director of Oncology at the U.

S. Food and Drug Administration (FDA), and in her new role will be responsible for medical strategy and oversight. With insights gleaned from her years at the FDA, Dr.

Singh is in a unique position to help existing and future clients optimize development and navigate a complex regulatory environment. Motivated by a desire to accelerate breakthrough treatments in oncology and rare disease, Dr. Singh brings to Precision a multi-dimensional understanding of drug development along with deep experience as a medical oncologist.

Dr. Singh will also provide medical and strategic support for business development activities and continue her active public presence as a thought leader for important issues facing the life sciences industry. "The wealth of experience that Dr.

Singh brings to Precision from over a decade of experience at the FDA and National Cancer Institute will be invaluable to our organization, our clients and, ultimately, patients," said , President, Clinical Solutions, at Precision for Medicine. "She is a proven leader in precision medicine, novel trial design and innovative regulatory initiatives designed to expedite clinical development. We are excited to add Dr.

Singh's unique skill set to our leadership team." Dr. Si.